Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-17T03:21:04.581Z Has data issue: false hasContentIssue false

FC03.03 - Drug consumption, health service use and outcome in opiate addicts in Europe: An 18-month follow-up from athens to zurich

Published online by Cambridge University Press:  16 April 2020

V. Reissner
Affiliation:
Department of Addiction Medicine, University and Medical School Essen, Essen, Germany
A. Kokkevi
Affiliation:
Department of Psychiatry, University Mental Health Research Institute (UMHRI), Athens, Greece
L. DiFuria
Affiliation:
Servizio Per Le Tossicodipendenze 1, Padova, Italy
F. Schiffano
Affiliation:
Department of Addictive Behaviour & Psychological Medicine, St. Georges Hospital Medical School, London, UK
R. Room
Affiliation:
Centre for Social Research on Alcohol and Drugs. Stockholm University, Stockholm, Sweden
R. Stohler
Affiliation:
Department of Psychiatry, University of Zurich (PUK), Zurich, Switzerland
N. Scherbaum
Affiliation:
Department of Addiction Medicine, University and Medical School Essen, Essen, Germany

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The aim of the TREAT-study (Treatment-systems Research on European Addiction Treatment) is the comparison of the course of predominantly opiate dependent patients from six European regions concerning severity of illness, health service use and heroin-use.

Method:

TREAT is a collaborative multi-centre-study conducted in Athens, Essen, London, Padua, Stockholm and Zurich which includes three repeated measures over a period of 18 month (T1-T3). Apart from the Europ-ASI, questionnaires for comorbid disorders and the utilisation of the treatment system were administered. The sample comprised about 100 subjects per region diagnosed with opiate addiction. 317 patients (53%) were retrieved for all three measures.

Results:

With some exceptions in all centres health service use by patients could be increased during the observation period. The severity of addiction decreased in almost all regions.

In a statistical model comprising all subjects who completed the study, the best predictor for abstinence was the number of detoxification treatments but also participation in long-term rehabilitative therapy. Patients with additional severe alcohol consumption at the beginning of the study had a higher risk for continuous drug use.

A second regression-model assumed that participants who had dropped out were still dependent on opiates. Again the combination of heroin and alcohol appeared to be a negative predictor. Patients in methadone maintenance treatment suffering from major depression showed a more positive outcome.

Discussion:

Regional differences concerning patients´ characteristics, health services and drop-out rates give reason for a cautious interpretation. The study describes high- and low-risk-groups as hints for the effective allocation of resources.

Type
Free Communications
Copyright
Copyright © European Psychiatric Association 2008
Submit a response

Comments

No Comments have been published for this article.